Novan, Inc. - NOVN

SEC Filings Our NOVN Tweets

About Gravity Analytica

Recent News

11.04.2026 - Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026
10.30.2026 - Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin
10.06.2026 - Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3%
08.13.2026 - Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
08.03.2026 - Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026
07.24.2026 - Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders
06.30.2026 - Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes
05.28.2026 - Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
05.14.2026 - Pelthos Therapeutics Announces First Quarter 2026 Financial Results
05.01.2026 - Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026

Recent Filings